146 related articles for article (PubMed ID: 27453514)
1. A Prospective Analysis of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation.
Serletis-Bizios A; Durand E; Cellier G; Tron C; Bauer F; Glinel B; Dacher JN; Cribier A; Eltchaninoff H
Am J Cardiol; 2016 Sep; 118(6):866-872. PubMed ID: 27453514
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
[TBL] [Abstract][Full Text] [Related]
3. Early discharge after transfemoral transcatheter aortic valve implantation.
Barbanti M; Capranzano P; Ohno Y; Attizzani GF; Gulino S; Immè S; Cannata S; Aruta P; Bottari V; Patanè M; Tamburino C; Di Stefano D; Deste W; Giannazzo D; Gargiulo G; Caruso G; Sgroi C; Todaro D; di Simone E; Capodanno D; Tamburino C
Heart; 2015 Sep; 101(18):1485-90. PubMed ID: 26076940
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.
Barbanti M; Baan J; Spence MS; Iacovelli F; Martinelli GL; Saia F; Bortone AS; van der Kley F; Muir DF; Densem CG; Vis M; van Mourik MS; Seilerova L; Lüske CM; Bramlage P; Tamburino C
BMC Cardiovasc Disord; 2017 Oct; 17(1):259. PubMed ID: 29017461
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial.
Durand E; Le Breton H; Lefevre T; Gilard M; Himbert D; Alcazar MU; Bettinger N; Auffret V; Didier R; Chevalier B; Béziau DM; Iung B; Eltchaninoff H
Arch Cardiovasc Dis; 2020; 113(6-7):391-400. PubMed ID: 32418883
[TBL] [Abstract][Full Text] [Related]
6. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
[TBL] [Abstract][Full Text] [Related]
7. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
8. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.
Gonska B; Seeger J; Keßler M; von Keil A; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2017 Aug; 106(8):590-597. PubMed ID: 28283746
[TBL] [Abstract][Full Text] [Related]
9. Short Length of Stay After Elective Transfemoral Transcatheter Aortic Valve Replacement is Not Associated With Increased Early or Late Readmission Risk.
Sud M; Qui F; Austin PC; Ko DT; Wood D; Czarnecki A; Patel V; Lee DS; Wijeysundera HC
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438738
[TBL] [Abstract][Full Text] [Related]
10. Comparing post-operative resource consumption following transcatheter aortic valve implantation (TAVI) and conventional aortic valve replacement in the UK.
Awad W; Mathur A; Baldock L; Oliver S; Kennon S
J Med Econ; 2014 May; 17(5):357-64. PubMed ID: 24621135
[TBL] [Abstract][Full Text] [Related]
11. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
12. Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation.
Husser O; Kessler T; Burgdorf C; Templin C; Pellegrini C; Schneider S; Kasel AM; Kastrati A; Schunkert H; Hengstenberg C
Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):141-8. PubMed ID: 26542175
[TBL] [Abstract][Full Text] [Related]
13. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
14. Incidence, Predictors, and Mid-Term Outcomes of Percutaneous Closure Failure After Transfemoral Aortic Valve Implantation Using an Expandable Sheath (from the Optimized Transcatheter Valvular Intervention [OCEAN-TAVI] Registry).
Nara Y; Watanabe Y; Kozuma K; Kataoka A; Nakashima M; Hioki H; Kawashima H; Nagura F; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Yamamoto M; Hayashida K
Am J Cardiol; 2017 Feb; 119(4):611-617. PubMed ID: 27939382
[TBL] [Abstract][Full Text] [Related]
15. Safety and predictors of next-day discharge after elective transfemoral transcatheter aortic valve replacement.
Rathore S; Latyshev Y; Emore S; Rowe J; Foerst J
Cardiovasc Revasc Med; 2017 Dec; 18(8):583-587. PubMed ID: 28551423
[TBL] [Abstract][Full Text] [Related]
16. Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay.
Lauck SB; Wood DA; Baumbusch J; Kwon JY; Stub D; Achtem L; Blanke P; Boone RH; Cheung A; Dvir D; Gibson JA; Lee B; Leipsic J; Moss R; Perlman G; Polderman J; Ramanathan K; Ye J; Webb JG
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):312-21. PubMed ID: 27116975
[TBL] [Abstract][Full Text] [Related]
17. Sutureless versus Transfemoral Transcatheter Aortic Valve Implant: A Propensity Score Matching Study.
Santarpino G; Vogt F; Pfeiffer S; Dell'Aquila AM; Jessl J; Cuomo F; von Wardenburg C; Fischlein T; Pauschinger M; Schwab J
J Heart Valve Dis; 2017 May; 26(3):255-261. PubMed ID: 29092108
[TBL] [Abstract][Full Text] [Related]
18. Analysis of length of stay after transfemoral transcatheter aortic valve replacement: results from the FRANCE TAVI registry.
Durand E; Avinée G; Gillibert A; Tron C; Bettinger N; Bouhzam N; Gilard M; Verhoye JP; Koning R; Lefevre T; Van Belle E; Leprince P; Iung B; Le Breton H; Eltchaninoff H
Clin Res Cardiol; 2021 Jan; 110(1):40-49. PubMed ID: 32335689
[TBL] [Abstract][Full Text] [Related]
19. Vascular Complications and Bleeding After Transfemoral Transcatheter Aortic Valve Implantation Performed Through Open Surgical Access.
Leclercq F; Akodad M; Macia JC; Gandet T; Lattuca B; Schmutz L; Gervasoni R; Nogue E; Nagot N; Levy G; Maupas E; Robert G; Targosz F; Vernhet H; Cayla G; Albat B
Am J Cardiol; 2015 Nov; 116(9):1399-404. PubMed ID: 26414600
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL
Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
